SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the publication of a case study highlighting the use of ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

Enveda, a biotechnology company using AI to translate nature into new medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) ...

Vernal keratoconjunctivitis (VKC) is an ocular disorder characterized by severe inflammation affecting both the cornea and ...

The firm is highly encouraged by management’s enthusiasm for the upcoming atopic dermatitis readout in December. Cash remains constrained given the level of clinical activity, with Q3-ending cash ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened risk of developing food allergies. The desire to prevent food allergies ...

In addition, the now expected decline in revenues from $150 million in 2025 to $125 million implies a significant ...

Medically reviewed by Susan Bard, MDCheilitis is a group of inflammatory conditions that cause the skin of the lips to become ...

The company is also evaluating soquelitinib to treat soquelitinib in patients with moderate to severe atopic dermatitis in a ...

The rising prevalence of allergic diseases such as food allergies, allergic rhinitis, asthma, and atopic dermatitis is a ...